Evidence-based digital therapeutics validated through clinical trials. Delivering measurable outcomes across mental health, autism, stroke rehabilitation, and healthcare economics.
Clinically validated digital mental health solutions with 73% PHQ-9 score reduction. Evidence-based CBT, mindfulness, and AI-powered therapy validated through 47 clinical trials with 28,000+ participants.
Revolutionary autism intervention technology with 72% early intervention success rate. Evidence-based ASD digital therapeutics validated through 142 RCTs with 13,588 participants using digital EIBI, PRT, and JASPER protocols.
Advanced stroke rehabilitation technology with 89% functional independence rate. Evidence-based neurorehabilitation through 157 RCTs with 24,891 stroke survivors using CIMT, VR therapy, and AI-powered neuroplasticity protocols.
Transform value-based care with $4,280 PMPY savings, 312% ROI, and 4.5-star quality ratings. CMS-approved reimbursement pathways with $38.1M cumulative savings per 100,000 lives across 147 health systems.
Partner with Swiv for next-generation digital therapeutics research. Clinical trial infrastructure, digital biomarker platform, and AI/ML research tools with 40% reduced trial costs and accelerated timelines.
Our digital therapeutics platform has been validated through over 350 randomized controlled trials with 67,000+ participants, demonstrating consistent efficacy across diverse patient populations and clinical conditions.